SearchDictionaryMobileLogin

Clinical application of prostaglandin E1 in cases of occlusive arterial disease.

AbstractFor the present time, intraarterial infusion of PGE1 is the treatment of choice for impending gangrene. But because of its technical difficulties and unpleasant side effects, mentioned earlier, intravenous administration of PGE1 should be considered in some cases.
AuthorsY Mishima
JournalAdvances in prostaglandin, thromboxane, and leukotriene research (Adv Prostaglandin Thromboxane Leukot Res) Vol. 15 Pg. 547-8 ( 1985) ISSN: 0732-8141 UNITED STATES
PMID2936166 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Alprostadil
Topics
  • Alprostadil (therapeutic use, toxicity)
  • Arterial Occlusive Diseases (drug therapy)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Humans